|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burkhart RA, Ronnekleiv-Kelly SM and
Pawlik TM: Personalized therapy in hepatocellular carcinoma:
Molecular markers of prognosis and therapeutic response. Surg
Oncol. 26:138–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li C, Miao R, Liu S, Wan Y, Zhang S, Deng
Y, Bi J, Qu K, Zhang J and Liu C: Down-regulation of miR-146b-5p by
long noncoding RNA MALAT1 in hepatocellular carcinoma promotes
cancer growth and metastasis. Oncotarget. 8:28683–28695.
2017.PubMed/NCBI
|
|
4
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC,
Huang CH, Lee YS, Yen TC and Hsieh SY: MicroRNA-214 downregulation
contributes to tumor angiogenesis by inducing secretion of the
hepatoma-derived growth factor in human hepatoma. J Hepatol.
57:584–591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li DP, Fan J, Wu YJ, Xie YF, Zha JM and
Zhou XM: MiR-155 up-regulated by TGF-β promotes
epithelial-mesenchymal transition, invasion and metastasis of human
hepatocellular carcinoma cells in vitro. Am J Transl Res.
9:2956–2965. 2017.
|
|
9
|
Sakabe T, Azumi J, Umekita Y, Toriguchi K,
Hatano E, Hirooka Y and Shiota G: Prognostic relevance of miR-137
in patients with hepatocellular carcinoma. Liver Int. 37:271–279.
2017. View Article : Google Scholar
|
|
10
|
von Felden J, Heim D, Schulze K, Krech T,
Ewald F, Nashan B, Lohse AW and Wege H: High expression of micro
RNA-135A in hepatocellular carcinoma is associated with recurrence
within 12 months after resection. BMC Cancer. 17:602017. View Article : Google Scholar
|
|
11
|
Li L, Qu YW and Li YP: Over-expression of
miR-1271 inhibits endometrial cancer cells proliferation and
induces cell apoptosis by targeting CDK1. Eur Rev Med Pharmacol
Sci. 21:2816–2822. 2017.PubMed/NCBI
|
|
12
|
Zhong J, Liu Y, Xu Q, Yu J and Zhang M:
Inhibition of DIXDC1 by microRNA-1271 suppresses the proliferation
and invasion of prostate cancer cells. Biochem Biophys Res Commun.
484:794–800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Z, Huang C and Hao D: MicroRNA-1271
inhibits proliferation and promotes apoptosis of multiple myeloma
cells through inhibiting smoothened-mediated Hedgehog signaling
pathway. Oncol Rep. 37:1261–1269. 2017. View Article : Google Scholar
|
|
14
|
Liu X, Ma L, Rao Q, Mao Y, Xin Y, Xu H, Li
C and Wang X: MiR-1271 inhibits ovarian cancer growth by targeting
cyclin G1. Med Sci Monit. 21:3152–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu H, Wang H, Liu X and Yu T: miR-1271
inhibits migration, invasion and epithelial-mesenchymal transition
by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Biochem
Biophys Res Commun. 472:346–352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Xu L and Jiang L: miR-1271
promotes non-small-cell lung cancer cell proliferation and invasion
via targeting HOXA5. Biochem Biophys Res Commun. 458:714–719. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santamaria PG, Moreno-Bueno G, Portillo F
and Cano A: EMT: Present and future in clinical oncology. Mol
Oncol. 11:718–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jolly MK, Ware KE, Gilja S, Somarelli JA
and Levine H: EMT and MET: Necessary or permissive for metastasis?
Mol Oncol. 11:755–769. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu
K and Liu Q: SREBP-1 has a prognostic role and contributes to
invasion and metastasis in human hepatocellular carcinoma. Int J
Mol Sci. 15:7124–7138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Y, Bao Y and Yang W: Regulatory miRNAs
in colorectal carcinogenesis and metastasis. Int J Mol Sci.
18:182017. View Article : Google Scholar
|
|
22
|
Gong J, Wang ZX and Liu ZY: miRNA-1271
inhibits cell proliferation in neuroglioma by targeting fibronectin
1. Mol Med Rep. 16:143–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong D, Zhang G, Ma H and Jiang G:
miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK.
Neoplasma. 62:559–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding
Y, Shu Y and Liu P: miR-1271 regulates cisplatin resistance of
human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR and
BCL2. Anticancer Agents Med Chem. 14:884–891. 2014. View Article : Google Scholar
|
|
25
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bessette DC, Qiu D and Pallen CJ: PRL
PTPs: Mediators and markers of cancer progression. Cancer
Metastasis Rev. 27:231–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Kirby CE and Herbst R: The
tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum
and the mitotic spindle and is required for normal mitosis. J Biol
Chem. 277:46659–46668. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng
L, Chen F, Peng F and Li X: MiR-339–5p regulates the growth, colony
formation and metastasis of colorectal cancer cells by targeting
PRL-1. PLoS One. 8:e631422013. View Article : Google Scholar
|
|
30
|
Hu JY, Yi W, Wei X, Zhang MY, Xu R, Zeng
LS, Huang ZJ and Chen JS: miR-601 is a prognostic marker and
suppresses cell growth and invasion by targeting PTP4A1 in breast
cancer. Biomed Pharmacother. 79:247–253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flores-Pérez A, Marchat LA,
Rodríguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D,
Maciel-Dominguez A, de la Cruz OH, Fonseca-Sánchez M, Ruíz-García
E, et al: Suppression of cell migration is promoted by miR-944
through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC
Cancer. 16:3792016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang F, Liang J, Wang WQ, Sun JP, Udho E
and Zhang ZY: PRL3 promotes cell invasion and proliferation by
down-regulation of Csk leading to Src activation. J Biol Chem.
282:5413–5419. 2007. View Article : Google Scholar
|
|
33
|
Liang F, Luo Y, Dong Y, Walls CD, Liang J,
Jiang HY, Sanford JR, Wek RC and Zhang ZY: Translational control of
C-terminal Src kinase (Csk) expression by PRL3 phosphatase. J Biol
Chem. 283:10339–10346. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abdollahi P, Vandsemb EN, Hjort MA, Misund
K, Holien T, Sponaas AM, Rø TB, Slørdahl TS and Børset M: Src
Family kinases are regulated in multiple myeloma cells by
phosphatase of regenerating liver-3. Mol Cancer Res. 15:69–77.
2017. View Article : Google Scholar
|
|
35
|
Achiwa H and Lazo JS: PRL-1 tyrosine
phosphatase regulates c-Src levels, adherence, and invasion in
human lung cancer cells. Cancer Res. 67:643–650. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y and Lazo JS: Metastasis-associated
phosphatase PRL-2 regulates tumor cell migration and invasion.
Oncogene. 31:818–827. 2012. View Article : Google Scholar
|
|
37
|
Liu X and Feng R: Inhibition of epithelial
to mesenchymal transition in metastatic breast carcinoma cells by
c-Src suppression. Acta Biochim Biophys Sin (Shanghai). 42:496–501.
2010. View Article : Google Scholar
|
|
38
|
Mon NN, Senga T and Ito S: Interleukin-1β
activates focal adhesion kinase and Src to induce matrix
metalloproteinase-9 production and invasion of MCF-7 breast cancer
cells. Oncol Lett. 13:955–960. 2017.PubMed/NCBI
|
|
39
|
Luo Y, Liang F and Zhang ZY: PRL1 promotes
cell migration and invasion by increasing MMP2 and MMP9 expression
through Src and ERK1/2 pathways. Biochemistry. 48:1838–1846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
